According to ICU Medical 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.04314. At the end of 2023 the company had a P/S ratio of 1.07.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.07 | -35.66% |
2022 | 1.66 | -56.75% |
2021 | 3.83 | 8.16% |
2020 | 3.54 | 15.51% |
2019 | 3.07 | -8.8% |
2018 | 3.36 | -0.09% |
2017 | 3.36 | -46.97% |
2016 | 6.34 | 19.45% |
2015 | 5.31 | 28.57% |
2014 | 4.13 | 34.66% |
2013 | 3.07 | 10.32% |
2012 | 2.78 | 34.99% |
2011 | 2.06 | 17.56% |
2010 | 1.75 | -21.83% |
2009 | 2.24 | -6.11% |
2008 | 2.39 | -8.89% |
2007 | 2.62 | -11.76% |
2006 | 2.97 | -15.6% |
2005 | 3.52 | -28.38% |
2004 | 4.91 | 12.37% |
2003 | 4.37 | -26.03% |
2002 | 5.91 | 4.8% |
2001 | 5.64 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Baxter BAX | 1.37 | 31.40% | ๐บ๐ธ USA |
Becton Dickinson BDX | 3.42 | 227.48% | ๐บ๐ธ USA |
Edwards Lifesciences EW | 8.88 | 751.50% | ๐บ๐ธ USA |
Teleflex TFX | 3.27 | 213.79% | ๐บ๐ธ USA |
Merit Medical MMSI | 3.39 | 224.85% | ๐บ๐ธ USA |
AngioDynamics ANGO | 0.7257 | -30.43% | ๐บ๐ธ USA |
Insulet PODD | 6.90 | 561.54% | ๐บ๐ธ USA |